Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;41(3):191-201.
doi: 10.1111/j.1600-0684.2012.00536.x. Epub 2012 Mar 20.

The non-human primate model of tuberculosis

Affiliations
Review

The non-human primate model of tuberculosis

D Kaushal et al. J Med Primatol. 2012 Jun.

Abstract

Non-human primates (NHPs) are used to model human disease owing to their remarkably similar genomes, physiology, and immune systems. Recently, there has been an increased interest in modeling tuberculosis (TB) in NHPs. Macaques are susceptible to infection with different strains of Mycobacterium tuberculosis (Mtb), producing the full spectrum of disease conditions, including latent infection, chronic progressive infection, and acute TB, depending on the route and dose of infection. Clearly, NHPs are an excellent model of human TB. While the initial aim of the NHP model was to allow preclinical testing of candidate vaccines and drugs, it is now also being used to study pathogenesis and immune correlates of protection. Recent advances in this field are discussed in this review. Key questions such as the effect of hypoxia on the biology of Mtb and the basis of reactivation of latent TB can now be investigated through the use of this model.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Different types of histopathological lesions observed during various Mtb infections of rhesus macaques. A. Centrally caseous lesion with peripheral rim of immune cells is the most typical type of pathology observed in NHPs infected with Mtb. B. A rare fibrotic lesion in a rhesus macaque infected with Mtb. C. Mineralization of a caseous lesion over time in a rhesus macaque infected with Mtb. D. Formation of highly inflamed multinucleated giant macrophages in a lesion from a rhesus macaque infected with Mtb. E. A rare lesion in a rhesus macaque infected with Mtb with a pathology that could be a precursor for cavitation. F. Post-primary lesions in the vicinity of primary, centrally caseous lesions in a rhesus macaque coinfected with Mtb and simian immunodeficiency virus.

Comment in

  • How well do you know your monkey TB model?
    Engel G, Wilbur AK, Jones-Engel L. Engel G, et al. J Med Primatol. 2013 Feb;42(1):46-7. doi: 10.1111/jmp.12030. Epub 2012 Dec 15. J Med Primatol. 2013. PMID: 23241171 Free PMC article. No abstract available.
  • How well do you know your monkeys?
    Kaushal D, Bohm RP Jr, Lackner AA. Kaushal D, et al. J Med Primatol. 2013 Feb;42(1):48-9. doi: 10.1111/jmp.12032. J Med Primatol. 2013. PMID: 23311579 Free PMC article. No abstract available.

References

    1. Dye C, Scheele C, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA. 1999;282:677–86. - PubMed
    1. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380–7. - PMC - PubMed
    1. Fletcher HA. Correlates of immune protection from tuberculosis. Curr Mol Med. 2007;7:319–25. - PubMed
    1. Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis. 2010;50:S260–6. - PubMed
    1. von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T, Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh CR, Pallangyo K. Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. Int J Tuberc Lung Dis. 2011;15:1087–92. - PMC - PubMed

Publication types